Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 13, 2026
Delpacibart Etedesiran Improves the Molecular Pathology of Myotonic Dystrophy Type 1 in the Phase 1/2 MARINA® Study
Tanya T Kwan, Qingying Meng, Nathaniel Delos Santos, et al.
European Heart Journal
|
November 27, 2020
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study
Jörg Täubel, Wilfried Hauke, Steffen Rump, et al.
Nature Biotechnology
|
October 12, 2012
Assessing unintended hybridization-induced biological effects of oligonucleotides
Morten Lindow, Hans-Peter Vornlocher, Donald Riley, et al.
Nucleic Acid Therapeutics
|
February 6, 2025
Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry Recommendations
Patrik Andersson, Sebastien A Burel, Heather Estrella, et al.
Endocrinology
|
January 24, 2009
Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeys
Michael M Swarbrick, Peter J Havel, Arthur A Levin, et al.
Nucleic Acids Research
|
April 17, 2026
Development of a DUX4-targeting antibody oligonucleotide conjugate as a therapy for FSHD
Barbora Malecova, David Sala, Garineh M Melikian, et al.
Nucleic Acids Research
|
May 24, 2023
Targeted tissue delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs)
Barbora Malecova, Rob S Burke, Michael Cochran, et al.
The New England Journal of Medicine
|
March 29, 2013
Treatment of HCV infection by targeting microRNA
Harry L A Janssen, Hendrik W Reesink, Eric J Lawitz, et al.
The New England Journal of Medicine
|
February 18, 2026
An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
Nicholas E Johnson, Li-Jung Tai, Johanna I Hamel, et al.
Nucleic Acids Research
|
April 4, 2025
AOC 1044 induces exon 44 skipping and restores dystrophin protein in preclinical models of Duchenne muscular dystrophy
Usue Etxaniz, Isaac Marks, Tyler Albin, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 13, 2026
Delpacibart Etedesiran Improves the Molecular Pathology of Myotonic Dystrophy Type 1 in the Phase 1/2 MARINA® Study
Tanya T Kwan, Qingying Meng, Nathaniel Delos Santos, et al.
European Heart Journal
|
November 27, 2020
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study
Jörg Täubel, Wilfried Hauke, Steffen Rump, et al.
Nature Biotechnology
|
October 12, 2012
Assessing unintended hybridization-induced biological effects of oligonucleotides
Morten Lindow, Hans-Peter Vornlocher, Donald Riley, et al.
Nucleic Acid Therapeutics
|
February 6, 2025
Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry Recommendations
Patrik Andersson, Sebastien A Burel, Heather Estrella, et al.
Endocrinology
|
January 24, 2009
Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeys
Michael M Swarbrick, Peter J Havel, Arthur A Levin, et al.
Nucleic Acids Research
|
April 17, 2026
Development of a DUX4-targeting antibody oligonucleotide conjugate as a therapy for FSHD
Barbora Malecova, David Sala, Garineh M Melikian, et al.
Nucleic Acids Research
|
May 24, 2023
Targeted tissue delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs)
Barbora Malecova, Rob S Burke, Michael Cochran, et al.
The New England Journal of Medicine
|
March 29, 2013
Treatment of HCV infection by targeting microRNA
Harry L A Janssen, Hendrik W Reesink, Eric J Lawitz, et al.
The New England Journal of Medicine
|
February 18, 2026
An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
Nicholas E Johnson, Li-Jung Tai, Johanna I Hamel, et al.
Nucleic Acids Research
|
April 4, 2025
AOC 1044 induces exon 44 skipping and restores dystrophin protein in preclinical models of Duchenne muscular dystrophy
Usue Etxaniz, Isaac Marks, Tyler Albin, et al.
Page
of 4